CCL2 (also called MCP-1) is a potent regulator of PCa cell migration and proliferation [31-34], and we have shown previously that NF-kB inhibitor can specially target its expression [23], therefore it was chosen for further investigations of its regulation by p536 in LNCaP cells. The gene discussed is CCL2; the disease is posterior cortical atrophy.